Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
6
Developing Species Specific Human Taeniasis Coproantigen Detection Immunoassays
Award last edited on: 3/12/19
Sponsored Program
SBIR
Awarding Agency
NIH : CDC
Total Award Amount
$150,000
Award Phase
1
Solicitation Topic Code
ODCDC
Principal Investigator
Hong Qi
Company Information
Qoolabs Inc
4186 Sorrento Valley Boulevard Suite D
San Diego, CA 92121
(858) 348-0988
info@qoolabs.com
www.qoolabs.com
Location:
Single
Congr. District:
51
County:
San Diego
Phase I
Contract Number:
200-2018-M-03277
Start Date:
00/00/00
Completed:
00/00/00
Phase I year
2018
Phase I Amount
$150,000
As the major cause of acquired epilepsy in developing countries Neurocysticercosis NCC is the infection of the human nervous system by the larvae of the pork tapeworm Taenia solium. Reportable cases are seen in non endemic countries because of increasing travel and immigration. Many infected persons are unaware of their infection or the potential risks of transmission to others. It is important to control and eliminate Tsolium to reduce the healthcare burden. For the elimination program to be implemented in endemic regions around the world low cost and sensitive detection tools are essential for identification and monitor the infections. Stool antigen coproantigen CoAg detection by immunoassays has been demonstrated to be effective. However currently there are no reliable source of renewable antibodies specific for Tsolium CoAg. As a result there are no commercially available CoAg immunoassays for TsoiumIn phase I of this study monoclonal antibodies specific to Tsolium CoAg will be generated. In Phase II of this study ELISA and rapid tests kits will be developed. The CoAg immunoassays will greatly facilitate the global effort of control and elimination of Tsolium infection in human
Phase II
Contract Number:
----------
Start Date:
00/00/00
Completed:
00/00/00
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.